Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
CORRESP Oct 3, 2017
UPLOAD Oct 3, 2017
S-3 Sep 22, 2017 S-3
8-K Sep 14, 2017 8-K
10-Q Aug 14, 2017 10-Q
8-K Aug 14, 2017 8-K
424B3 Jul 3, 2017 424B3
8-K Jun 30, 2017 8-K
8-K Jun 2, 2017 8-K
4 May 26, 2017 OWNERSHIP DOCUMENT
4 May 26, 2017 OWNERSHIP DOCUMENT
4 May 26, 2017 OWNERSHIP DOCUMENT
4 May 26, 2017 OWNERSHIP DOCUMENT
4 May 26, 2017 OWNERSHIP DOCUMENT
4 May 26, 2017 4
4 May 26, 2017 OWNERSHIP DOCUMENT
8-K May 11, 2017 8-K
10-Q May 11, 2017 10-Q
4 Apr 18, 2017 4
DEF 14A Apr 13, 2017 DEF 14A
8-K Apr 4, 2017 8-K
424B3 Mar 31, 2017 424B3
FWP Mar 30, 2017 FWP
EFFECT Mar 28, 2017
S-1/A Mar 28, 2017 S-1/A
← Newer Page 15 of 26 · 643 filings Older →